EMBO Molecular Medicine

Aims & Scope

EMBO Molecular Medicine is the top open access journal in the field of experimental medicine dedicated to science at the interface between translational and clinical research and basic life sciences.

We welcome original studies performed in cells and/or animals provided that they demonstrate evident human disease relevance.

We encourage submissions of first-in-human studies and analyses of patient samples.

EMBO Molecular Medicine publishes research papers as full-length Articles, short Reports and Resource articles.

In addition, the journal publishes Editorials and Reviews in innovative formats that target a broad and non-specialized audience, as well as News & Views, Opinions and Commentaries.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 6,890.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The amyloid hypothesis of Alzheimer's disease at 25 years

  Citation: 5060

  Authors: Dennis J, John

• MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

  Citation: 1328

  Authors: Marilena V., Carlo M.

• Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

  Citation: 709

  Authors: Jacques, Chantal, Aurélie, Pascale, Christelle, Luis G., Natalia, Mathieu, Thierry, Sampo, Arthur, Philippe, Nina, Philippe J., Rémy

• Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

  Citation: 639

  Authors: Tuan Zea, Qing Hao, Yoshio, Tetsuo, Seiichi, Ruby Yun‐Ju, Jean Paul

• Angiotensin II revisited: new roles in inflammation, immunology and aging

  Citation: 614

  Authors: Ariela, Paola, Giuseppe

• Inflammasomes in neuroinflammatory and neurodegenerative diseases

  Citation: 611

  Authors: Sofie, Sahana, Mohamed, Geert

• Resolution of inflammation: an integrated view

  Citation: 605

  Authors: Almudena, Mauro, Oliver

• Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

  Citation: 554

  Authors: Jose Miguel, M. Angela

• Development of micro<scp>RNA</scp> therapeutics is coming of age

  Citation: 545

  Authors: Eva, Sakari

• Synthetic lethal targeting of <i>PTEN</i> mutant cells with PARP inhibitors

  Citation: 537

  Authors: Ana M., Sarah A., Rachel, Afshan, Jessica R., Jung‐Sik, Todd, Christopher J., Alan